609O CLDN18.2 targeted antibody-drug conjugate (ADC), SHR-A1904, in patients (pts) with gastric/gastroesophageal junction cancer (GC/GEJC): A phase I study

R-H. Xu, Dan Ruan, Song Luo, Zuoxing Niu, Qiang Dang, Zhizhong Pan, Ying Zhang, X. Li, Hengyuan Li, Xin Xiao,

Annals of Oncology · 2024 · 10 citations · 0 references

Concepts